Taconic Capital Advisors’s Boston Scientific BSX Stock Holding History

Taconic Capital Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-200,000	Closed	-$8.86M	–	702
2022 Q1	$8.86M	Buy	+200,000	New	+$8.67M	0.24%	78
2021 Q1	–	Sell	-500,000	Closed	-$18M	–	377
2020 Q4	$18M	Buy	+500,000	New	+$18M	0.79%	22
2020 Q2	–	Sell	-1,100,000	Closed	-$35.9M	–	53
2020 Q1	$35.9M	Buy	+1,100,000	New	+$43M	2.11%	11
2019 Q1	–	Sell	-200,000	Closed	-$7.07M	–	56
2018 Q4	$7.07M	Hold	200,000	–	–	0.51%	31
2018 Q3	$218K	Buy	+200,000	New	+$6.99M	0.02%	43

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Taconic Capital Advisors's BSX Position: Q2 2022 in Review

Taconic Capital Advisors sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 370,000 shares — an estimated $16.4M sold.

Taconic Capital Advisors first reported a position in BSX in Q3 2018 and held it in 4 quarters. The position peaked at $16.4M in Q1 2022. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

Taconic Capital Advisors reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
Taconic Capital Advisors sold 370,000 Boston Scientific shares in Q2 2022, an estimated $16.4M.
Taconic Capital Advisors first reported a position in Boston Scientific in Q3 2018 and held it in 4 quarters.
Taconic Capital Advisors's Boston Scientific position peaked at $16.4M in Q1 2022.
878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Taconic Capital Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.